High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy - United Kingdom
doi 10.1038/s41417-018-0070-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Enhanced Expression of FCER1G Predicts Positive Prognosis in Multiple Myeloma

Journal of Cancer
Oncology
2020English

High Hepsin Expression Predicts Poor Prognosis in Gastric Cancer

Scientific Reports
Multidisciplinary
2016English

High Expression of Citron Kinase Predicts Poor Prognosis of Prostate Cancer

Oncology Letters
Cancer ResearchOncology
2020English

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma

Journal of Cancer
Oncology
2020English

High Expression of CDCA7 Predicts Tumor Progression and Poor Prognosis in Human Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2020English

High Nuclear/Cytoplasmic Ratio of Cdk1 Expression Predicts Poor Prognosis in Colorectal Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

High Sub-Clonal Fraction of 17p Deletion Is Associated With Poor Prognosis in Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

High Expression of Eukaryotic Initiation Factor�3M Predicts Poor Prognosis in Colon Adenocarcinoma Patients

Oncology Letters
Cancer ResearchOncology
2019English

Cortactin Expression Predicts Poor Survival in Laryngeal Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy